Loading…

Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature

Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma t...

Full description

Saved in:
Bibliographic Details
Published in:Current oncology (Toronto) 2021-01, Vol.28 (1), p.661-670
Main Authors: Kasherman, Lawrence, Doi, Jeffrey, Karakasis, Katherine, Schiff, Jeffrey, Kitchlu, Abhijat, Lheureux, Stephanie, Oza, Amit M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Solid organ transplant recipients on long-term immunosuppressive medication are at increased risk of developing malignancy, and treatment of advanced cancers with angiogenesis inhibitors in this context has not been widely studied. We present a case of recurrent high-grade serous ovarian carcinoma treated with paclitaxel and bevacizumab in the context of prior renal transplantation where the patient responded well to treatment with controlled toxicities, discussing the potential for increased rates of adverse events and drug interactions in this select population.
ISSN:1718-7729
1198-0052
1718-7729
DOI:10.3390/curroncol28010064